Processing

Please wait...

Settings

Settings

Goto Application

1. WO2016001885 - AMORPHOUS FORM OF ELIGLUSTAT HEMITARTARATE

Publication Number WO/2016/001885
Publication Date 07.01.2016
International Application No. PCT/IB2015/055024
International Filing Date 03.07.2015
IPC
A61K 31/4025 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
40having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
4025not condensed and containing further heterocyclic rings, e.g. cromakalim
C07D 319/18 2006.1
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
319Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
101,4-Dioxanes; Hydrogenated 1,4-dioxanes
14condensed with carbocyclic rings or ring systems
16condensed with one six-membered ring
18Ethylenedioxybenzenes, not substituted on the hetero ring
CPC
A61K 31/4025
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
40having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
4025not condensed and containing further heterocyclic rings, e.g. cromakalim
A61K 47/32
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers ; , poly(meth)acrylates, or polyvinyl pyrrolidone
A61K 47/38
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
38Cellulose; Derivatives thereof
A61K 9/10
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
10Dispersions; Emulsions
C07D 319/18
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
319Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
101,4-Dioxanes; Hydrogenated 1,4-dioxanes
14condensed with carbocyclic rings or ring systems
16condensed with one six-membered ring
18Ethylenedioxybenzenes, not substituted on the hetero ring
Applicants
  • DR. REDDY’S LABORATORIES LIMITED [IN]/[IN]
Inventors
  • VELAGA, Dharma Jagannadha Rao
  • PEDDY, Vishweshwar
  • VYALA, Sunitha
Priority Data
3293/CHE/201403.07.2014IN
Publication Language English (en)
Filing Language English (EN)
Designated States
Title
(EN) AMORPHOUS FORM OF ELIGLUSTAT HEMITARTARATE
(FR) FORME AMORPHE D'HÉMITARTRATE D'ELIGLUSTAT
Abstract
(EN) The present application relates to the solid state forms of Eliglustat hemitartrate and the processes for the preparation thereof. The application further provides solid dispersion of Eliglustat hemitartrate having Eliglustat hemitartrate in amorphous form.
(FR) La présente invention concerne des formes à l'état solide d'hémitartrate d'Eliglustat et leurs procédés de préparation. L'application concerne en outre une dispersion solide d'hémitartrate d'Eliglustat comprenant de l'hémitartrate d'Eliglustat sous forme amorphe.
Latest bibliographic data on file with the International Bureau